+36.1%
MRNA vs PSKY
-18.9%
+55.0%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | PSKY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +2.1% | +3.3% | +4.9% |
| 7D | -1.1% | -2.4% | +1.3% | -0.6% |
| 30D | +126.1% | +11.6% | +114.5% | +122.4% |
| 3M | +190.0% | +1.5% | +188.5% | +189.5% |
| 6M | +157.2% | +7.7% | +149.5% | +154.4% |
| YTD | +388.2% | -20.1% | +408.3% | +403.0% |
| 1Y | +467.0% | -38.3% | +505.3% | +504.9% |
| 3Y | +36.1% | -17.7% | +53.8% | +36.4% |
| All | +36.1% | -18.9% | +55.0% | +36.4% |
Cumulative growth
Daily Returns
Daily percentage return beside PSKY.
Daily Out/Under-Performance
Portfolio return minus PSKY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PSKY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded PSKY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling